AI will help find cure for cancer ‘within our lifetimes’, says Arm Holdings chief

AI will help find cure for cancer ‘within our lifetimes’, says Arm Holdings chief. Photograph: Malcolm Park/AlamyAI will help find cure for cancer ‘within our lifetimes’, says Arm Holdings chiefRene Haas also claims artificial intelligence could pave way for widespread use of humanoid robots within five years Business live – latest updates The boss of one of the UK’s biggest chip companies has claimed AI will be able to find a cure for cancer “in our lifetime”.

What happened

Rene Haas also claims artificial intelligence could pave way for widespread use of humanoid robots within five yearsBusiness live – latest updatesThe boss of one of the UK’s biggest chip companies has claimed AI will be able to find a cure for cancer “in our lifetime”. Rene Haas, chief executive of the chip designer Arm Holdings, said that, while modelling how a DNA marker is affected by cancer was currently “too complex” a problem for either humans or technology, computers were “going to solve it” in the future. Continue reading. . .

Big Boss Interview: Arm Holdings Rene HaasThe CEO of chip design company Arm tells the BBC AI will help cure cancer, lead to widespread humanoid robots in the next five years, but says its rapid growth is being held up by a shortage of chips needed in data centres. Haas told the BBC: “AI is going to … find a cure for cancer that today you and I, other humans [could] not in our lifetimes. Figure caption, Rene Haas predicts AI will change the way cancer cures are developedByFaisal IslamEconomics editorPublished8 September 2026, 00:05 BSTUpdated 8 hours agoThe boss of the biggest UK-headquartered tech firm has said that artificial intelligence will find a cure for cancer that humans cannot in our lifetimes.

Skip to main contentSkip to navigation As computers that run AI get more sophisticated they will eventually find a cancer cure, said Arm’s Rene Haas. Rene Haas, chief executive of the chip designer Arm Holdings, said that, while modelling how a DNA marker is affected by cancer was currently “too complex” a problem for either humans or technology, computers were “going to solve it” in the future. I believe in our lifetime, AI will help cure cancer.

The wider picture

Related topicsArtificial intelligenceCancerMedical researchARM HoldingsCompaniesMore on this storyOpenAI chief scientist warns no one is prepared for consequences of AIPublished1 day agoTime is running out for cyber security, warn top tech firmsPublished27 AugustAI boom will produce victors and carnage, tech boss warnsPublished28 January Explore more on these topicsArmAI (artificial intelligence)CancerMedical researchRobotsComputingHealthShareReuse this contentMore on this storyMore on this storyBBC News presenter Maryam Moshiri reveals she has incurable blood cancerArm boss in line for billion-dollar payday if chipmaker hits targets Genetically modified pig kidney keeps man alive for record nine months OpenAI hails ‘new era of artificial general intelligence’ with Astra model releaseArm looks to launch its own chip after landing Meta contractBill Gates calls for ‘human-reserved’ jobs in face of AI takeover‘A mouse can’t tell us what works’: UK scientists to grow miniature human organs for drug testingGPs’ advice service is causing cancer diagnoses to be missed, inquiry finds‘I see the incredible promise’: on set of an AI film shoot as new studios embrace controversial techWeight-loss drugs can cut breast cancer risk by up to 30%, studies suggestMost viewedMost viewed

“Modelling how a DNA marker is impacted by cancer – it’s too complex a problem, not only for humans today, but the computers that run AI. “However, going forward, as we feed more and more of the models into these computers, and the computers get more sophisticated to run the models, they’re going to solve it. ”Scientists are already using AI-driven tools in cancer research and testing. Haas added that AI would also pave the way for widespread humanoid robots within the next five years, but that chip shortages were stunting growth in the area.

It is the biggest tech company headquartered in Britain – valued at $269bn (£199bn). skip past newsletter promotionafter newsletter promotionHaas, who joined Arm in 2013 and became chief executive in 2022, was also recently named chief executive of SoftBank’s international business. Prof Chris Bakal, from the Institute of Cancer Research, London, and CEO of Sentinal4D, said the real question was no longer whether we use AI, it's what we feed it. "Job losses 'overstated'In a wide-ranging interview, Haas said the chips Arm designs would fuel self-learning AI robots "in a very large way" in manufacturing, cleaning, security, building bridges, and doing repairs within a decade.

What has been reported

Earlier this year, the NHS said more than 4 million patients received faster lung diagnosis thanks to funding in AI-powered X-ray tools. “With artificial intelligence, these robots can see, learn, and essentially be reprogrammed for new tasks,” he said. “So, in the service industry, the robot that was programmed to make a bed can also learn how to arrange the towels in a room, or clean the dustbins, or whatever you want to go off and do. ”Arm, which is listed in New York but retains its global headquarters in Cambridge, has about 500 users of its chip designs worldwide, including Apple, Samsung, Qualcomm and Nvidia.

The company employs more than 7,000 staff, including about 3,000 in the UK. The Japanese bank is one of the biggest tech investors in the world, with a stake in ChatGPT maker OpenAI. Haas stepped down from the board of British pharmaceutical giant AstraZeneca in April,Earlier this year, Arm also proposed a pay scheme for Haas that could make him a billionaire if he hits targets to turn the chip designer into a trillion-dollar company. Haas also told the BBC that AI would lead to widespread humanoid robots in the next five years, but that its current rapid growth was being held up by a shortage of chips needed to build data centres.

However, he was sceptical about the idea chips could be manufactured in the UK in the future.

What happens next

Arm designs the brains or CPUs of microchips already used in hundreds of billions of phones, cars, smartwatches and gadgets across the globe. Earlier this summer, the company's peak share price amid the AI boom made it, in cash terms, the most valuable UK-based company in history. "However, going forward, as we feed more and more of the models into these computers, and the computers get more sophisticated to run the models, they're going to solve it," said Haas, who also holds a key role in Arm's main owner, the Japan-based Softbank, which has a range of investments in tech including in OpenAI.

He said in labs like his, they are training AI on data generated themselves from patient samples. The future of medical AI will not belong to whoever builds the biggest computer. It will belong to whoever has the right measurements. "That kind of prediction could cut years from the time it takes to develop new treatments.

The report has been compiled by The Daily Waves using information reported across theguardian.com, bbc.co.uk. Details are presented according to the information available at the time of publication and may change as authorities, organisers or other relevant parties provide updates.